Security key
P8696W104
SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA)
CUSIP: P8696W104
Q1 2021 13F Holders as of 31 Mar 2021
- Security type / class
- Equity / Common Shares, par value US$0.001 per share
- Total 13F shares
- 6,694,343
- Total 13F value
- $43,301,798
- Share change
- +127,573
- SEC-reported price per share
- $6.47
- Number of holders
- 14
- Value change
- +$795,406
- Number of buys
- 4
- Number of sells
- 2
- Shares outstanding
- 71,872,133
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2021
Institutions
14
Top holders
10
SVA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2021
Previous quarter: Q4 2020
SINOVAC BIOTECH LTD SEC filings
SINOVAC BIOTECH LTD company facts
Broader feeds
Reporting periods
Holder history for CUSIP P8696W104
Recent filing periods:
Ownership snapshot
Top reported holders of SVA - SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
SAIF Advisors Ltd
Disclosed value leader
ORBIMED ADVISORS LLC
Comparable rows
15/15
Latest evidence
31 Dec 2020
13F
Lead comparable stake: 15%
Showing 1-6 of 15 holder rows.
Quick read
SAIF Advisors Ltd leads the comparable SEC ownership view at 15%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens SAIF Advisors Ltd's linked filing trail.
Comparable ownership
Top 5
SAIF Advisors Ltd
15%
Vivo Capital, LLC
8.2%
ORBIMED ADVISORS LLC
4%
RENAISSANCE TECHNOLOGIES LLC
3.3%
Neumann Advisory Hong Kong Ltd
0.44%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| SAIF Advisors Ltd |
13F
Company
|
15%
|
$69,752,000
10,780,820 shares
|
— | 31 Dec 2020 |
| Vivo Capital, LLC |
13F
Company
|
8.2%
|
$38,173,000
5,900,000 shares
|
— | 31 Dec 2020 |
| ORBIMED ADVISORS LLC |
13F
Company
|
4%
|
$72,000,000
2,839,500 shares
|
— | 31 Dec 2020 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
3.3%
|
$1,537,000
2,375,841 shares
|
— | 31 Dec 2020 |
| Neumann Advisory Hong Kong Ltd |
13F
Company
|
0.44%
|
$2,042,000
315,586 shares
|
— | 31 Dec 2020 |
| STATE STREET CORP |
13F
Company
|
0.22%
|
$1,041,000
160,875 shares
|
— | 31 Dec 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
14
Shares
6,694,343
Rows available
14
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2021 vs Q4 2020 Across Filers
Q4 2020 holders
14
Q1 2021 holders
14
Holder diff
0
| Investor | Q4 2020 Shares | Q1 2021 Shares | Share Diff | Share Chg % | Q4 2020 value | Q1 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend